ClinicalTrials.Veeva

Menu
Advanced Research Institute | Reno, NV logo

Advanced Research Institute | Reno, NV

Research site

Site insights

Top conditions

Top treatments

Vonoprazan
Lansoprazole
IW-3718
ION224
EYE103
CC-93538
LY3298176
Vibegron
Eluxadoline
Loperamide

Parent organization

This site is a part of Advanced Research Institute

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Active trials

5 of 18 total trials

A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Disease

This is a Phase 2a/b, randomized, double-blind, placebo-controlled, parallel-group, 6-arm study to evaluate the efficacy and safety of amlitelimab in...

Enrolling
Coeliac Disease
Celiac Disease
Dietary Supplement: SIGE
Drug: Placebo

This study will investigate the effect of tirzepatide on the reduction of morbidity and mortality in adults living with obesity and provide additiona...

Active, not recruiting
Overweight
Obesity
Drug: Placebo
Drug: Tirzepatide

This study is researching an experimental drug called dupilumab. The study is focused on participants with active eosinophilic gastritis (EoG) with o...

Enrolling
Eosinophilic Duodenitis (EoD)
Eosinophilic Gastroenteritis
Drug: Dupilumab

This study is an open-label, uncontrolled study design to evaluate the long-term safety and tolerability of treatment with CC-93538. The study will e...

Active, not recruiting
Eosinophilic Esophagitis
Drug: CC-93538

The goal of this clinical trial is to evaluate if the study drug, CIN-103, can help reduce the symptoms associated with irritable bowel syndrome with...

Enrolling
Irritable Bowel Syndrome with Diarrhea
Drug: CIN-103
Drug: Placebo

Trial sponsors

Phathom Pharmaceuticals logo
Allergan logo
Celgene logo
C
E
Exact Sciences Corporation logo
E
F
G
Ionis Pharmaceuticals logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems